AU2002330518A1 - Compositions containing a ruthenium(III) complex and a heterocycle - Google Patents

Compositions containing a ruthenium(III) complex and a heterocycle

Info

Publication number
AU2002330518A1
AU2002330518A1 AU2002330518A AU2002330518A AU2002330518A1 AU 2002330518 A1 AU2002330518 A1 AU 2002330518A1 AU 2002330518 A AU2002330518 A AU 2002330518A AU 2002330518 A AU2002330518 A AU 2002330518A AU 2002330518 A1 AU2002330518 A1 AU 2002330518A1
Authority
AU
Australia
Prior art keywords
heterocycle
ruthenium
iii
complex
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002330518A
Other versions
AU2002330518B2 (en
Inventor
Bernhard Keppler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Niiki Pharma Acquisition Corp 2
Original Assignee
Niiki Pharma Acquisition Corp 2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10103565A external-priority patent/DE10103565B4/en
Application filed by Niiki Pharma Acquisition Corp 2 filed Critical Niiki Pharma Acquisition Corp 2
Publication of AU2002330518A1 publication Critical patent/AU2002330518A1/en
Assigned to FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH reassignment FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH Amend patent request/document other than specification (104) Assignors: Refer to Publication History
Application granted granted Critical
Publication of AU2002330518B2 publication Critical patent/AU2002330518B2/en
Assigned to NIIKI PHARMA INC. reassignment NIIKI PHARMA INC. Request for Assignment Assignors: FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH
Assigned to NIIKI PHARMA ACQUISITION CORP. 2 reassignment NIIKI PHARMA ACQUISITION CORP. 2 Request to Amend Deed and Register Assignors: NIIKI PHARMA INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002330518A 2001-01-26 2002-01-28 Compositions containing a ruthenium(III) complex and a heterocycle Ceased AU2002330518B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10103565.9 2001-01-26
DE10103565A DE10103565B4 (en) 2001-01-26 2001-01-26 Compositions containing a ruthenium (III) complex and a heterocycle
PCT/EP2002/000863 WO2002059135A1 (en) 2001-01-26 2002-01-28 Compositions containing a ruthenium(iii) complex and a heterocycle

Publications (2)

Publication Number Publication Date
AU2002330518A1 true AU2002330518A1 (en) 2003-02-06
AU2002330518B2 AU2002330518B2 (en) 2006-10-05

Family

ID=7671867

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002330518A Ceased AU2002330518B2 (en) 2001-01-26 2002-01-28 Compositions containing a ruthenium(III) complex and a heterocycle

Country Status (7)

Country Link
US (3) US7338946B2 (en)
EP (1) EP1353932A1 (en)
JP (2) JP2004528292A (en)
AU (1) AU2002330518B2 (en)
CA (1) CA2436260C (en)
DE (1) DE10103565B4 (en)
WO (1) WO2002059135A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2686834C (en) * 2007-06-11 2014-05-27 Bernhard Keppler Method of manufacturing a ruthenium complex
EP2418956A4 (en) * 2009-04-17 2013-04-03 Niiki Pharma Inc Method of treating hepatocellular carcinoma
AU2010328023B2 (en) * 2009-12-11 2016-07-14 Niiki Pharma Acquisition Corp. 2 Method of treating pancreatic cancer
US8383673B2 (en) * 2010-03-19 2013-02-26 City University Of Hong Kong Nitridoosmium(VI) complexes for treatment of cancer
ES2539160T3 (en) * 2010-04-19 2015-06-26 Niiki Pharma Inc. Gastric Cancer Treatment Procedure
CN102946878A (en) * 2010-04-23 2013-02-27 尼基制药公司 Method of treating prostate cancer
WO2011139867A2 (en) * 2010-04-29 2011-11-10 Niiki Pharma Inc. Method of treating brain cancer
AU2011279835A1 (en) * 2010-07-17 2013-02-07 Niiki Pharma Acquisition Corp. 2 Method of treating refractory cancer
CN103153303A (en) * 2010-07-18 2013-06-12 尼基制药公司 Combination therapy using a ruthenium complex
EP2632459B1 (en) * 2010-10-25 2017-08-16 Niiki Pharma Inc. Method of treating neuroendocrine tumors
JP2014500259A (en) * 2010-11-17 2014-01-09 ニーキ ファーマ インコーポレイテッド How to treat blood cancer
JP2014516966A (en) 2011-05-17 2014-07-17 ニキ ファーマ アクィジション コーポレイション ２ Pharmaceuticals and methods for treating cancer
WO2013070988A2 (en) * 2011-11-09 2013-05-16 Niiki Pharma Inc. Method of treating osteosarcoma
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same
CA3062369A1 (en) 2017-05-05 2018-11-08 Intezyne Technologies, Inc. Manufacture of trans-[tetrachlorobis(1h-indazole)ruthenate (iii)] and compositions thereof
CN115554401A (en) * 2022-09-24 2023-01-03 重庆医科大学 Preparation of unsupported multifunctional nanoparticles based on ruthenium complex and anti-tumor application of unsupported multifunctional nanoparticles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843069A (en) * 1984-07-24 1989-06-27 Asta Pharma Ag Medicament formulations containing ruthenium compounds with an antitumoral action
DE19612291A1 (en) * 1996-03-28 1997-10-02 Bernhard K Prof Dr Dr Keppler Pharmaceutical preparations containing ruthenium (III) complexes which have an anti-tumor effect

Similar Documents

Publication Publication Date Title
AU2002229065A1 (en) Compositions containing inclusion complexes
AU781269C (en) Pharmaceutical compositions
AU2002243267A1 (en) Dietary supplement compositions
AU2002313236A1 (en) Medicinal compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2001295657A1 (en) Formulation containing wax-esters
AU2001282617A1 (en) Compositions for external preparations
AU2002341205A1 (en) Pharmaceutical compositions comprising cyclosporin
AU2001253179A1 (en) Defoamer compositions and uses therefor
AU2003276549A1 (en) Pharmaceutical compositions containing a biguanide-glitazone combination
AU2002330518A1 (en) Compositions containing a ruthenium(III) complex and a heterocycle
AU2001277940A1 (en) Dietary supplement compositions
AU2002349635A1 (en) Fill-out container
AU2001273919A1 (en) Pharmaceutical compositions
AU6941801A (en) Package for pasta
AU2002316927A1 (en) Composition containing phytase
AU4430601A (en) Computer telephony integration
AU2001287677A1 (en) Ruthenium complexes containing carboids
AU2001235764A1 (en) Compositions
AU2001250326A1 (en) Vertebrate globin
AU2002367173A1 (en) Antifungal compositions
AU4853101A (en) Respiratory compositions
AU2002359571A1 (en) A softening-through-the-wash composition
AU2002346223A1 (en) Medicinal compositions